AstraZeneca, Daiichi Sankyo get Enhertu FDA approval for HER2-low metastatic breast cancer

pallavi123- August 7, 2022 0

Enhertu FDA approval : AstraZeneca and Daiichi Sankyo have secured approval for Enhertu (trastuzumab deruxtecan) from the US Food and Drug Administration for the treatment ... Read More

Lantern Pharma gets FDA nod for Harmonic phase 2 clinical trial of LP-300

pallavi123- July 17, 2022 0

Lantern Pharma said that the US Food and Drug Administration (FDA) has authorized it to move ahead with its Harmonic phase 2 clinical trial of ... Read More

FDA rejects Lilly’s sintilimab as first line treatment of NSCLC

pallavi123- March 27, 2022 0

The US Food and Drug Administration (FDA) has rejected the biologics license application (BLA) of Eli Lilly and Company (Lilly)’s sintilimab injection in nonsquamous non-small ... Read More

Lupin signs agreement for biosimilar Pegfilgrastim in Brazil

pallavi123- December 4, 2021 0

Lupin Limited has signed an exclusive distribution and marketing agreement with Biomm SA for biosimilar Pegfilgrastim in Brazil. The Indian pharma company had earlier secured ... Read More

Roche’s Tecentriq secures FDA approval for small cell lung cancer treatment

pharmanewsdaily- March 30, 2019 0

Roche’s subsidiary, Genentech, has announced a significant breakthrough with the US Food and Drug Administration (FDA) approval of Tecentriq (atezolizumab). This new approval marks a ... Read More

Merck secures EC approval for Keytruda in combination therapy for lung cancer

pharmanewsdaily- September 12, 2018 0

Merck has achieved a significant milestone by obtaining approval from the European Commission (EC) for its cancer immunotherapy, Keytruda (pembrolizumab), to be used in combination ... Read More

Cantex Pharmaceuticals’ CX-01 receives FDA fast track designation in acute myeloid leukemia

pharmanewsdaily- August 27, 2018 0

Cantex Pharmaceuticals, a Florida-based biotechnology company, has achieved a significant milestone by securing Fast Track designation from the US Food and Drug Administration (FDA) for ... Read More